Prof. Gilles Lambert, Ph.D - a leading researcher and thought leader in the field of blood lipid metabolism.
Dr. Gilles Lambert was awarded a PhD in Pathophysiology from the University of Paris in 1998. Gilles further specialized in lipidology, first as a post-doctoral fellow at the Molecular Disease Branch of the National Institutes of Health (Bethesda MD, USA) and then as a senior research fellow at the Heart Research Institute (Sydney, NSW, Australia).
Dr Lambert is Professor in Cell Biology at Univ. of La Réunion Medical School (France) and group leader, Inserm laboratory of Diabetes & Atherothrombosis of the Univ. Hospital of La Réunion.
Since 2004, Dr Lambert has conducted seminal research projects on PCSK9, a major inhibitor of the LDL receptor. He received several competitive research grants in Australia and in France to study the cardiovascular benefits and potential side effects of PCSK9 inhibition.